Registration Strip Icon for monitor Customisable watchlists with full streaming quotes from leading exchanges, such as LSE, NASDAQ, NYSE, AMEX, Bovespa, BIT and more.

0RN3 Takeda Pharmaceutical Co Ltd

49.35
0.00 (0.00%)
22 Nov 2024 - Closed
Delayed by 15 minutes
 Name  Symbol  Market  Type  ISIN  Description 
 Takeda Pharmaceutical Co Ltd LSE:0RN3 London Stock Exchange Ordinary Share JP3463000004 TAKEDA PHARMACEUTICAL ORD SHS
     Change  % Chg  Cur  Bid  Offer  High  Low  Open  Volume  Chg Time   RN  NRN 
   0.00 0.00 49.35 0.00 0.00 0.00 0.00  0.00 00:00:00   
 Sector  Turnover  Profit  EPS - Basic  PE ratio  Mkt Cap 
 Pharmaceutical Preparations 4.28T 144.07B 91.0423 0.54 78.09B
 Type  Size  Price  Time  Units 
   0.00  
 
Recent News
DateTimeSource
HeadlineMore 0RN3 News
22/11/202410:00ALNCHutchmed to get payment from Takeda as Fruzaqla launched in Japan
31/10/202416:26ALNCTOP NEWS: Takeda lifts outlook, eyes return to sustainable growth
24/09/202407:49ALNCTakeda Pharmaceutical says Fruzaqla cancer drug gets Japan backing
24/06/202409:00ALNCIN BRIEF: Hutchmed China notes Takeda obtains EU approval for Fruzaqla
09/05/202408:36ALNCTOP NEWS: Takeda Pharmaceutical profit sinks as expenses mount
22/04/202419:41ALNCTakeda, Astellas and Sumitomo to create new drug discovery company
27/03/202412:56PRNUSEmpathy in Action: Takeda's Global Initiative Brings IBD Challenges to the Forefront in the UAE
Period
Draw mode
Data Downloads for 0RN3

Export historical price information open, high, low, close, volume (OHLCV) to Excel

Intraday price data (2 weeks, 1 minute bars)
Technical Analysis for Takeda Pharmaceutical Co Ltd
Get quick technical analysis for Takeda Pharmaceutical Co Ltd.
Price Indicators
Evaluate in real-time the trend for this stock with base on twelve different studies.
Candlesticks
Verify the trend for the closing and opening times for this stock or defined reversal patterns.
Support & Resistance
Automatically plot the main lines for support and resistance for this tock highlighting the main levels.

Latest Takeda Pharmaceutical Co Ltd Articles